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Abstract 
Background- Research on pharmacist provided care and services has rarely focused on medication cost and affordability. This study 
aims to bridge the gap by examining pharmacists’ perspectives of medication costs and affordability.  
Objective- To explore pharmacists’ perceptions about medication cost burden for patients, their communication with patients about 
i) ability to afford medications, ii) price, and iii) ways to reduce medication cost burden, their perceptions about ways to help improve 
affordability of medications and the barriers to communication. 
Method- A cross sectional exploratory study design was utilized. A convenience sample of pharmacists working in community 
pharmacies in Brooklyn was approached and asked to complete a survey. The survey questions examined the extent to which 
pharmacists: 1) perceived medication cost to be a burden, 2) initiated discussion about i) ability to afford medications, ii) price of 
medications, iii) ways to reduce cost burden. Pharmacists were also asked to opine on how to improve affordability of medications 
and their perceived barriers for such communication with the patients. Questions were formulated to differentiate pharmacists’ 
perceptions and behaviors in regards to dealing with patients with (PWI) and without insurance (PWOI). Data was analyzed using 
SPSS version 17.0.  
Result- A total of twenty-six pharmacists out of 54 approached participated in the study.  Majority of the pharmacists reported the 
cost of medication to be extremely/very burdensome for PWOI (73%) than PWI (23%). In contrast, more pharmacists reported 
initiating a discussion very often/always about affordability with PWI (35%) than PWOI (20%). Discussions about price of medications 
were more common than discussions about affordability and ways to reduce medication burden. On an average, 33% of the 
pharmacists suggested generics as a way to improve affordability of the medications for PWI and PWOI.  
Conclusion- Patient–pharmacist communication on affordability and ways to reduce cost burden occurs very infrequently. 
Understanding the perspectives on patient –pharmacist communication on medication cost may help in developing effective 
strategies and may help reduce cost-related medication non-adherence. 
 
 
Introduction 
In the United States healthcare system, spending on 
prescription medications is at an all high. The total sales for 
prescription medications alone in the US were $259.1 billion 
in 2010.1 While much of the costs for prescriptions are 
estimated to be paid for by insurance companies, recent 
reports indicate that approximately one third of the US 
population pays out of pocket (OOP) for their prescription 
medications.1 Due to the high cost of medications, paying 
OOP for medications can be a huge burden in the current 
economic environment; especially for 16% of the US 
population that are currently uninsured. 2,3Insurance plays an 
important role amongst patients as it predicts their access to 
medical care and health care facilities provided. 1, 2, 3 
 
The effects of high OOP costs on patient adherence and 
patient outcomes can be devastating. Several studies show 
that cost related non-adherence (CRN) to prescription 
medication leads to declining health status, increased health 
complications, more frequent visits to emergency 
departments, acute care hospitals, nursing home admissions 
and general health services.4 Hence non-adherence to 
medications increases the cost and reduces the quality of 
care offered to patients and prevents patients from receiving 
the necessary medical treatment.3, 5 
 
Communication about cost and insurance related issues holds 
high importance as high cost medication and copayments 
have a direct impact on patient non-adherence to 
medications.7-11   While there is a vast literature on factors 
affecting medication adherence and cost related non-
adherence, the literature on patient-provider communication 
about medication costs is scant and mostly focused on 
patient-physician communication about costs. This literature 
suggests that patients would like their physicians to discuss 
prescription medication cost and cost reduction strategies 
with them but the same studies also suggest that physicians 
rarely talk to their patients about the cost of their 
medications.12-16 These same studies also report that patients 
rarely initiate discussions about costs with their providers and 
that patient discomfort, embarrassment, perceptions of 
insufficient time, belief that providers will not have viable 
solutions, are important barriers to patient initiated 
conversation about costs of medications. Research also 
suggests that discussions about drug costs differ by age, 
ethnicity and income of the patients. Physicians are more 
likely to discuss drug costs with younger, white 16 and low-
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income patients.15 Lack of adequate physician knowledge 
about the cost of prescription medications and coverage 
details of insurance formularies has been identified as 
primary sources of lack of discussion between patients and 
physicians.17-25 
 
Given the limited literature on patient-provider 
communication about medication costs, there is a critical gap 
in addressing patient concerns about medication costs and 
affordability. Research is needed to assess the varied sources 
of knowledge that patients’ use to discuss medication cost 
and affordability.26 Pharmacists, who are often considered to 
be medication experts and the last frontier for addressing 
patient issues about medications, can play a big role in 
discussing medication costs and affordability with their 
patients as they know the costs of medications and ways to 
reduce medication costs for their patients. For example, 
pharmacists may help patients switch to low cost generic 
medications, help patients with identifying prescription 
assistance or discount programs, or offer discounts that 
would lower patient costs. However, very little is known 
about the extent to which pharmacists and patients have 
discussions about medication costs and affordability. There 
are many studies of patient-pharmacist communication but 
very rarely the focus is directly and solely on patient-
pharmacist communication about cost of medications and 
affordability.27-31This study aimed to fill that gap and explore 
four main research questions: 1) To what extent do 
pharmacists perceived medication cost to be a burden for 
their patients?  2) To what extent do pharmacists initiate 
discussion about i) ability to afford medications, ii) price of 
medications, iii) ways to reduce cost burden? And 3) from a 
pharmacists’ perspective what are some ways to help 
improve affordability of medications for their patients? And 
4) what are pharmacists’ barriers to communication with 
patients about medication costs and affordability? 
 
Theoretical Framework 
The theoretical framework for this study was based on 
Gerbner’s theory of communication32 as a dyadic transaction 
between two participants whose behaviors in the encounter 
is influenced by several factors including participant’s past 
experiences. A literature review presented by Shah and 
Chewing 33 provide an excellent overview of this theory and 
how it can apply in the context of patient-pharmacist 
communication. The literature on patient-provider 
communication about medication costs was utilized to 
identify the factors to be included for this study.  
Methodology 
Given that this was designed as a pilot study, an exploratory 
cross sectional study design was utilized. Pharmacists working 
in pharmacies within a 2-mile radius of the Arnold and Marie 
Schwartz College of Pharmacy and Health Sciences 
(AMSCOP), Long Island University (LIU) in Brooklyn were 
established as the sampling frame. A Google Maps search 
revealed approximately 35 community pharmacies in the 2-
mile radius of the AMSCOP. The student investigator 
approached each pharmacy in the sampling frame and sought 
the participation of pharmacists. A total of 54 pharmacists 
were approached, of which 26 agreed to participate in the 
study. Upon consent, they were asked to complete a survey. 
The paper-based survey was self-administered by the student 
investigator to participating pharmacists. The survey was 
primarily based on acquiring the extent of discussion 
between patients-pharmacists on mediation cost acquisition 
issues. The survey included questions primarily on the extent 
of communication between the pharmacist and patients’ 
regards to medication price, affordability and ways to reduce 
medication cost burden and pharmacists perceived barriers 
to communication with patients. Given that patient’s 
insurance may play an important role in such discussions, 
questions were formulated to differentiate the extent to 
which pharmacists initiated cost related discussions 
(affordability, price and ways to reduce cost burden) to 
patients with insurance  (PWI) and without insurance (PWOI). 
There were 2 questions measuring each construct 
(affordability, price and ways to reduce cost burden).  A five 
point Likert type scale (not at all—always) was used as the 
response scale for each question. Pharmacists’ perceptions 
about medication cost as a burden for their patients was also 
measured using two items. Item one asked pharmacists to 
indicate the approximate percentage of patients for whom 
medication cost is a burden whereas the second item asked 
participants to indicate the extent to which they believed 
medication cost as burdensome for their patients with 
insurance and patients without insurance using a 5 point 
Likert scale (extremely burdensome-not at all burdensome). 
To elicit strategies that pharmacists could use to improve 
affordability of medications, pharmacists were asked to 
indicate ways in which they could help improve affordability 
of medications using an open-ended question. Pharmacist 
demographics such as age, gender, ethnicity, working hours, 
# of years having worked at the store, the type of store, 
average # of hours worked per week, average # of 
prescriptions dispensed, filled per day for patients without 
insurance, and estimated percentage of patients who had 
concern about cost of medication, difficulty in paying for 
medications and lastly percentage of patients who don't use 
medications and do not pick up medications because they 
cannot afford, these were items that were also collected. In 
addition to this, pharmacists were also asked about the 
extent to which patients initiate discussion about cost of 
medications. 
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Majority of the survey questions were developed by the 
investigators based on the literature available on patient-
physician communication about medication costs and 
affordability. Prior to the study initiation, the survey was 
pretested using 5 AMSCOP faculty members who hold a New 
York state pharmacist license and were not involved in the 
research. Face and content validity was established during 
the pretest. Subsequent to the pretest, LIU institutional 
review board approved the study protocol.  
 
All collected data were entered into SPSS version 17.0 and 
analyzed using descriptive statistics. The open-ended 
responses were coded by the student investigator based 
upon the common themes of improving the affordability of 
medications. The reliability for the different constructs on the 
survey was examined using Cronbach’s alpha. Bivariate 
analyses were conducted to examine whether age, gender 
ethnicity and type of pharmacy influence pharmacists’ 
discussion with patients about the cost, price and ability to 
afford medications.  
 
Results 
Out of the 54 pharmacists who were approached, 26 agreed 
to participate resulting in a 48% participation rate. The 
majority of the respondents enrolled in the study were males 
(65%). The demographics also showed most respondents to 
be Non–Hispanics (45.8%), working at independent stores 
(50%), working 40 hours per week (35%) and between 30-40 
years of age (43%). (Table 1)  
 
Non-participating pharmacists worked mostly at Pharmacy 
chain (64%) and (34%) at independent pharmacies and 35% 
were between 40-50 years of age. 
 
The Cronbach’s alpha for the constructs examining the extent 
of communication on price, affordability and ways to reduce 
medication cost were 0.89, 0.86 and 0.85 respectively.  
 
Pharmacist Perceptions about Medication Cost As a Burden 
for Patients 
On an average, pharmacists reported that 70% of their 
patients had concerns with paying for their medications. 
Figure 1 presents responses provided for the second item 
measuring pharmacist perceptions about medication cost as a 
burden for patients. Pharmacists who indicated medication 
costs to be extremely/very burdensome for patients without 
insurance were 34% and 38% respectively; where as 23% of 
the pharmacists indicated medication costs to be 
extremely/very burdensome for patients with insurance. 
 
 
 
Pharmacist-Patient Communication about Medication Costs 
a. Pharmacist initiated discussion of medication cost 
and affordability 
Table 2 presents the descriptive analysis of pharmacist 
responses on questions related to pharmacist-patient 
communication about medication costs. Approximately 15% 
of the pharmacists reported that they always initiated a 
discussion on the ways to reduce cost related burden for 
patients without insurance. Very few of the pharmacists very 
often initiated a discussion with patients with insurance on 
the ability to afford the medications (23%), price (31%) and 
ways to reduce medications costs. (27%) Where as on an 
average 35% of the pharmacists somewhat often initiated 
discussions about ability to afford the medications (35%), 
price (23%) and ways to reduce medications costs (47%) with 
patients without insurance. 
 
b. Patient initiated discussion of medication cost and 
affordability 
Approximately 35% of the patient without insurance very 
often initiated discussion about medication cost and 
affordability with pharmacists where as 30% of the patients 
with insurance very often initiated discussion about cost of 
medication and affordability with pharmacists. Figure 2 
 
There were no significant differences found between 
pharmacists’ gender, ethnicity, and type of pharmacy and 
pharmacists’ initiation about cost related communication 
with their patients. However, there was a significant 
difference among pharmacist’s age groups with regards to 
their initiation about cost related communication with 
patients (p=0.01).  
 
Strategies to Reduce Medication Cost Burden 
In response to the open ended questions, pharmacists 
reported a variety of strategies to reduce cost related 
burdens for their patients. These strategies included 
providing coupons for buying the medication, discounts on 
the price of medications, switching medications to generics, 
calling the physician to make switches and recommending 
over the counter products. Table 3 presents the number and 
percentage of instances where pharmacists mentioned the 
strategies. On an average 33% of the pharmacists reported 
suggesting generics to patients without insurance and 
patients with insurance.  However approximately 32% of the 
pharmacists reported working with insurance plan for 
patients with insurance and 35% pharmacists reported 
providing discounts to patient without insurance.  
 
Pharmacist’s Barrier to Communication with Patients about 
Medication Costs and Affordability 
http://z.umn.edu/INNOVATIONS                    2014, Vol. 5, No. 2, Article 156                           INNOVATIONS in pharmacy   3 
 
Student Paper PHARMACY PRACTICE 
 
 
Approximately 60% of the pharmacists reported that lack of 
time with a busy schedule as the prime reason for the lack 
discussion regards medication cost and affordability with the 
patients.  Pharmacists also reported that patients are in a 
hurry (45%) and patients don’t care (40%) as other reasons 
for the absence of such communication. 
 
Discussion 
There were no known studies on patient-pharmacist 
communication that focused primarily on patient affordability 
and costs of medication. This exploratory study aimed to 
explore the nature and extent of cost related pharmacist-
patient communication and also examined pharmacist’s 
perceptions of cost as a burden and ways to reduce the 
burden. In this pilot study, we found that pharmacists feel 
that paying for medications was a concern for approximately 
70% of their patients. While no earlier comparisons are 
available to identify if this number has increased in the 
current economic environment, the fact that pharmacists feel 
that nearly every seven in ten have concerns about paying for 
medications is striking. Future studies should examine why 
pharmacists believe such high number of patients have 
concerns about paying for medications and the 
characteristics of such patients. 
 
One would assume that if patients had concerns about paying 
for medications, pharmacists would be discussing price, 
affordability and ways to reduce costs with their patients very 
commonly. However, this pilot study found that pharmacists 
very infrequently discussed cost related issues with all their 
patients. Also, this study found that pharmacists more 
commonly discussed price of medications more than 
affordability and ways to reduce cost burden. Future studies 
should qualitatively examine how pharmacists discuss price 
without discussing affordability and ways to reduce cost 
burden. Interestingly, pharmacists also had more discussions 
about these issues with patients with insurance than patients 
without insurance. This is counterintuitive, as one would 
expect more discussion with a patient paying the full price 
rather than only OOP costs. Again, more research is needed 
to explore why discussions with patients with insurance are 
more common than with patients without insurance. 
 
This study also examined barriers to patient-pharmacist 
communication about medication costs and affordability and 
found that the reasons reported by pharmacists for lack of 
such communication are similar to earlier studies of patient-
pharmacist communication.27, 28 In this study, pharmacists 
cited lack of time, patients’ in a hurry, patients’ don’t care as 
primary reasons. Future studies should develop interventions 
to target some of these barriers. Such interventions may 
enhance patient satisfaction and reduce the problems such as 
cost related under use of medications. It may also help 
pharmacists generate more revenue for their pharmacies as 
improving adherence may help the pharmacy generate more 
sales and improve customer loyalty. 
 
Strategies indicated by pharmacists in this study as a way to 
reduce cost related burden add to those found in the patient-
physician communication literature. Pharmacists in this study 
suggested use of generics, discounts and coupons and 
providing information to seek an effective insurance plan as 
ways to reduce cost burden. Efforts need to be directed to 
increase the use of these strategies by pharmacists and to 
educate patients about initiating discussions about ways to 
reduce their cost burden.  
 
There are several limitations of this study that should be 
taken into consideration while interpreting the results. This 
was a pilot study utilizing a convenience sample located in a 
single geographic location. Thus, generalizability of the study 
is limited. The investigator collected the surveys personally 
and hence the mode of data collection could have lead to 
participation, recall bias and social desirability. Finally, due to 
small sample size, bivariate relationships may be exposed to 
an inflated alpha and decreased power. A close-ended survey 
was utilized in the study taking in account the busy schedule 
of the pharmacists. Future research should look to validate 
the findings of this study under more diverse and 
generalizable circumstances. Additionally more efforts 
needed to understand the impact of medication cost 
communication on patient’s satisfaction, adherence and 
outcomes. 
 
Conclusion 
Discussions related to price, affordability and ways to reduce 
the medication cost related burden occur rarely between the 
pharmacist and the patients and are more likely to occur 
between patients with insurance rather than patients without 
insurance. Pharmacists helped reduce the medication cost 
related burden on patients by offering them generics, 
coupons, and discounts and over the counter medications. 
More comprehensive research is needed to assess the 
perspectives on patient –pharmacist communication on 
medication cost, in developing effective strategies. Efforts 
should be directed to advocate and beget the frequency of 
cost related communication between patient and pharmacist. 
More emphasis on research in determining the impact of cost 
related communication by pharmacist on the patient’s health 
outcomes and adherence to medications. 
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Table 1: Demographics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Pharmacists’ perception about medication cost as a burden for patients 
 
 
0%
10%
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0% 
23.10% 
53.80% 
19.20% 
3.80% 
34.60% 
38.50% 
19.20% 
3.80% 3.80% 
Burden to patients with
insurance
Burden to patients without
insurance
Age                                                                                             N (%) 
25-35 12 (52.1%) 
36-45 6 (26%) 
46-55 5 (21.7%) 
  
Gender  
Males 17 (65.4%) 
Females  9 (34.6%) 
  
Ethnicity 
Non –Hispanic White 11 (45.8%) 
African American 2 (8.3%) 
Hispanic 1 (4.2%) 
Asian Pacific Islander 5 (20.8%) 
Other 5 (20.8%) 
  
Type of Pharmacy 
Pharmacy Chain 10 (38.5%) 
Independent Single Store  13(50%) 
Independent Multiple Store 3 (11.5%) 
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Figure 2: Pharmacists perceived extent to which patients initiate discussion about medication cost and affordability 
 
 
 
 
 
Table 2. Pharmacist-Patient Communication about Medication Costs and Affordability 
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19.20% 
11.50% 
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38.50% 
34.60% 
15.40% 
Patients with Insurance
Patients without Insurance
RPh initiated 
discussion 
about…. 
For Patient With Insurance N (%) For Patient Without Insurance N (%) 
Not At 
All 
Rarely Somewhat 
Often 
Very 
Often 
Always Not At 
All 
Rarely Somewhat 
Often 
Very 
Often 
Always 
 Ability to afford 
medications 
1  
(4%) 
3 
(12%) 
13  
(50%) 
6 
(23%) 
3  
(12%) 
2  
(8%) 
10 
(39%) 
9  
(35%) 
3 
(12%) 
2  
(8%) 
Price of 
medications 
1  
(4%) 
3 
(12%) 
6  
(23%) 
8 
(31%) 
8  
(31%) 
3  
(12%) 
8  
(31%) 
6  
(23%) 
6  
(23%) 
3 
(12%) 
Ways to reduce 
medications 
costs related 
burden 
2  
(8%) 
5 
(19%) 
7  
(27%) 
7 
(27%) 
5  
(19%) 
2  
(8%) 
7 
(27%) 
12  
(47%) 
1 
(4%) 
4  
(15%) 
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Table 3. Strategies To Help Patients Reduce Medication Cost Related Burden 
 
Pharmacists would…. For Patients With Insurance For Patients Without Insurance 
Work with insurance plan to 
make changes  
6 (31.6%) 2 (10%) 
Provide Options to Patient: Either 
use generics or call Medical 
Practitioner to switch drugs 
1 (5.5%) 2 (10%) 
Suggest generics 7(36.8%) 6 (30%) 
Use Multiple Strategies: 
Discounts, generics and call 
Medical Practitioner to switch to 
over the counter medications 
2 (10.5%) 1 (5%) 
Provide Discounts/Coupons 1 (5.3%) 7 (35%) 
Refer to Technician 1 (5.3%) 1 (5%) 
Recommend Over The Counter 
medications 
1 (5.3%) 1 (5%) 
 
 
Sample of survey questions 
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